Rapid diagnostic tests

搜索文档
 OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
 Globenewswire· 2025-10-29 19:30
BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 1 ...
 OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
 Globenewswire· 2025-10-29 04:22
Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective  OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board; Jack Kenny Appointed as Chair of the Board BETHLEHEM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...
 OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
 Globenewswire· 2025-07-22 04:05
 文章核心观点 OraSure Technologies公司定于2025年8月5日下午5点(美国东部时间)举行财报电话会议,讨论2025年第二季度财务结果和业务进展 [1]  会议安排 - 电话会议将进行网络直播,可在公司网站投资者关系页面观看,直播链接为https://orasure.gcs-web.com/events-and-presentations ,需至少提前10分钟点击链接注册并获取访问权限,会议结束后不久将在网站存档约一年 [2] - 想在会议中提问的参与者需通过链接https://register-conf.media-server.com/register/BIdfa47088da4a422f967ac3a63ee20f09 预注册,注册后将通过电子邮件提供访问详情 [3]  公司介绍 - 公司通过可操作的洞察改变健康,推动人们在任何地方获得医疗保健的转变,凭借便捷测试和样本管理解决方案的创新,提高医疗保健的可及性、质量和价值 [3] - 公司与全资子公司DNA Genotek Inc.和Sherlock Biosciences, Inc.是快速诊断测试以及样本收集和稳定设备的开发、制造和分销领域的领导者,产品组合全球销售 [3]  联系方式 - 投资者联系:副总裁Jason Plagman,邮箱investorinfo@orasure.com [3] - 媒体联系:企业传播总监Amy Koch,邮箱media@orasure.com [3]
 OraSure Announces $40 Million Stock Repurchase Program
 Newsfilter· 2025-03-24 19:30
 文章核心观点 - 奥拉苏尔技术公司董事会授权未来24个月内回购至多4000万美元普通股,资金来自手头现金 [1]  公司动态 - 公司董事会授权未来24个月内回购至多4000万美元普通股,资金来自手头现金 [1] - 公司可通过多种符合州和联邦证券法的方法回购股份,回购数量和时间由管理层决定,且公司可自行决定随时修改、暂停或终止该计划,无需提前通知 [2]  公司介绍 - 奥拉苏尔技术公司通过可操作的洞察改变健康,推动人们在任何地方与医疗保健建立联系,凭借便捷测试和样本管理解决方案的创新改善医疗保健的可及性、质量和价值 [3] - 公司及其全资子公司是快速诊断测试以及样本收集和稳定设备的开发、制造和分销领域的领导者,产品全球销售 [3]  联系方式 - 投资者联系:副总裁Jason Plagman,邮箱investorinfo@orasure.com [5] - 媒体联系:企业传播总监Amy Koch,邮箱media@orasure.com [5]


